Pioneering research in Microdosing GLP-1 The AgelessRx Applied Science Team is leading the first clinical trial focused on the healthspan-enhancing potential of Microdosing GLP-1 Ongoing observational study including long-term tracking of diverse health outcomes in over 1,000 patients using a growing real-world database of patient-reported data Clinical collaborations are currently in development to expand the scope and impact of this research How it works GLP-1s bind to GLP-1 receptors beyond the brain and gut, reaching the heart, kidneys, blood vessels, and immune cells Shown to support signaling to longevity-related pathways like AMPK and mTOR, affecting key Hallmarks of Aging like oxidative stress, inflammation, DNA repair, mitochondrial function, and autophagy At low doses, may subtly restore balance to hormone signaling, reduce inflammation (immune cells), improve cognitive function, and cardiometabolic health Effects may vary based on individual biology and with factors including inflammation, weight, lifestyle, metabolic health, and health history
Patients prescribed DOACs (apixaban, rivaroxaban, edoxaban, dabigatran) require renal function monitoring at least annually, and more frequently in those aged over 75, with low body weight, intercurrent illness, or chronic kidney disease
For researchers, this is the difference between knowing you have 80mg of something and knowing you have a verified 50/10/10/10 split of the correct compounds
Indian tradition states that the herb brings strength and healing but since these first uses, huge alternative benefits of the herb have been discovered, too
Giri, K
